Clinical Trial Update: Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A completed safety study evaluating mesenchymal precursor cells in patients with type 2 diabetes across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Mesenchymal precursor cells (mesenchymal precursor cells)

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: COMPLETED